The formula exhibited significant therapeutic effects in an AA mouse model, evidenced by a reduction in Th2 and Th17 cell populations, restoration of the Th1/Th2 and Th17/Treg immune balance, alleviation of eosinophilic airway inflammation, and a decrease in total IgE and HDM-sIgE levels in serum. The gene discussed is IGHE; the disease is inflammatory response.